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ABSTRACT:  
 
Telemedicine which has been widely adopted in developed countries to reach all its citizens irrespective of their 
location is only being used for education purposes or disaster relief in developing countries. Since developing 
countries already suffer inadequate healthcare provision especially in remote areas, it would be essential to 
implement telemedicine practices for daily clinical uses rather than education use. This research argues that to 
understand the future of telemedicine in developing countries, both well-established technology innovations 
adoption factors as well as co-innovation factors should be addressed.  In the context of healthcare provision, we 
propose a conceptual framework that integrates the healthcare resources and the organisational affiliations in co-
innovation.  
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1. INTRODUCTION 
 
A great challenge face the healthcare sector globally especially in the management of chronic and multiple diseases 
due to the high rise of the aging population [62]. However, use of Information and Communication Technologies 
(ICT) has bridged the gap especially in the exchange of medical information from one site to another. Aided by high 
capacity digital networks, powerful computer hardware and software as well as high resolution digital image 
compression, the healthcare sector has been greatly transformed in areas that have adopted the technologies [21].  
 
To explain the phenomenon, the term telemedicine was coined by Thomas Bird in 1970s [54] which literally means 
healing at a distance [78] [69]. The prefix tele is a Greek word meaning far or distance [78] [14] [69]. Nevertheless, 
the implementation of telemedicine is primarily used in developed countries due to the high levels of economic and 
infrastructure development [44]. According to [75], implementation of telemedicine in the U.S.A healthcare system 
could save the country approximately $4.28 billion just from reducing transfers of patients from one location such as 
a nursing home for medical exams at hospitals, physicians’ offices or other caregiver locations. In addition, the UK 
National Health Service anticipates slashing the healthcare costs by adopting ehealth procedures. However, groups 
that suffer from inadequate healthcare services mainly the under-developed and developing countries have the least 
implementation of telemedicine.  
 
The World Health Organization (WHO) claims that less than half of the population in developing countries have 
adequate access to healthcare. According to [30] and [31], poor infrastructure and economic level has contributed to 
failure in the delivery of quality healthcare these countries. However, [41] claim that politicians have a great impact 
on the development of a country irrespective of its economic status.  
Telemedicine is a technology that bridges the gap between healthcare providers and the patient which is mainly as a 
result of geographical separation [65]. This is a common phenomenon in underserved communities especially in 
developing countries [43]. Therefore, telemedicine allows physicians in remote areas to liaise with specialised 
consultants who are located both locally and internationally without leaving their physical location. Although 
telemedicine cannot increase the number of specialised doctors in a country, it helps use the scarcely available 
resources more efficiently [3]. In addition, scholars have argued that telemedicine saves lives since it links the 
unequipped healthcare centres in remote areas with the equipped healthcare centres in urban areas [43] [20] [64] 
[35].  
 
Telemedicine is considered as an innovation like any other technological innovation [54] [68]. However, studies 
show that the cost of implementing a telemedicine project is high and a single organisation is likely to face 
challenges in funding the project [54] [32] [68] [12].  
According to [49] [2] and [8], innovation collaboration among various organisations can ease the burden of cost on 
an individual organisation. Therefore, the research concepts of this study will be drawn from the following areas as 
shown in Figure 1. 
 
 
 
 
Figure 1:  Research concepts of the literature 
 
 
Various researchers claim that lack of funding to sustain telemedicine projects in developing countries is the main 
hindrance to its implementation [66] [6] [12]. Nevertheless, recent studies show that co-innovation can enable both 
private and public organisations pool resources and share high costs involved in healthcare technological 
innovations [32] [12]. Aided by the literature concepts gathered, this study will be aimed at demonstrating that co-
innovation can benefit the complex telemedicine innovation process.  
 
 
1.1 Background information to telemedicine in healthcare 
 
[66] broadly defines telemedicine as delivery of health care services where distance is a critical factor by all health 
care professionals using ICT for the exchange of valid information for diagnosis, treatment and prevention of 
diseases and injuries, research and evaluation and for continuing education of health care providers, all in the 
interest of advancing the health of individuals and their communities.  
Various researchers have defined the term telemedicine in different ways as shown in Table 1. 
 
Table 1:  Definition of telemedicine  
 
Terminology 
 
Definition 
 
Reference 
 
 
 
 
 
 
 
 
 
 
Telemedicine 
The use of ICT in the delivery of health services to enable 
provider–patient and provider–provider consultation despite 
geographical separation. 
 
[43] 
Exchange of medical information from one site to another 
via electronic communications for the health and education 
of the patient or health care provider and the purpose of 
improving patient care. 
 
[21] 
The utilization of communication technologies to deliver or 
support any aspect associated with medical care, regardless 
of physical distances separating patient and provider. 
 
[44] 
Telemedicine is an integrated system of healthcare delivery 
that employs telecommunications and computer technology 
as a substitute for face-to-face contact between provider and 
client. 
 
[6] 
The use of medical information exchanged from one site to 
another via electronic communications such as two-way 
video, email, smart phones, wireless tools and other forms of 
ICT to patient’s clinical health status.  
 
[65] 
The practice of medicine using audio, visual and data 
communications. 
[60] 
 
 
1.2 History of telemedicine 
The exact date when health care was administered from a distance is unknown [78]. However, [16] claim that in the 
15
th
 century, information about bubonic plague was transmitted across Europe using bonfires. Later in mid-19
th 
century, telegraphy was used to transmit casualty list and medical supplies list during the American civil war [69]. 
Also x-ray images were transmitted [16]. In late 19
th
 century to early 20
th
 century, Einthoven transmitted electric 
cardiac signals of patients in a hospital 1
1
/2 km away using a string galvanometer and telephone wires.  
Telephone network was also used to transmit amplified sounds of stethoscope. Later in 1920s, radio links were used 
by Norwegian doctors to provide advice to sick ship crew [54]. This was initially made possible by the introduction 
of Morse code and later voice. Starting early 1950s, the analogue methods that were used earlier were replaced by 
digital communication techniques through the introduction of television. This was a major influence to the 
development of the current telemedicine [16] [69]. By late 1950s, closed circuit television and video communication 
was made possible [78]. This has been in use up to date.  
 
According to [64], telemedicine is a technology that bridges the gap between healthcare providers and the patient 
which is mainly as a result of geographical separation. Geographical barrier is a common phenomenon in 
underserved communities especially in developing countries [44]. As reported by [13], telemedicine allows less 
experienced doctors to liaise with specialised consultants who are hundreds of miles away. In addition, it helps use 
the scarcely available resources more efficiently [3]. Furthermore, telemedicine cannot increase the number of 
physicians in a country or influence their location [51].  
Scholars have argued that telemedicine saves lives since it links the unequipped healthcare centres in remote areas 
with the equipped healthcare centres in urban areas [9] [20] [64] [35].  
 
1.3 Telemedicine evaluation 
 
Various factors have to be considered to determine the type of telemedicine application to be used. According to [6], 
the decision on the type of telemedicine to be used should be viewed from healthcare providers and societal 
perspective where each perspective has various concerns as shown in Figure 2. In addition, each perspective must 
take into account of the intended application of the telemedicine technology as well as the type of technology 
available. Therefore, each consideration must take a three dimensional matrix cube which considers the perspective, 
application and technology to be used. 
 
 
 
Figure 2: Three-Dimensional Model for Telemedicine Evaluation [5] 
 
 
1.4 The future of telemedicine 
According to [31] and [70], the future of telemedicine is determined by three key factors as shown in Figure 3. 
 
 
 
Figure 3: The future of telemedicine 
Economic factors 
  
According to [31], most health systems are supported through public funding as well as contribution of the private 
sector. [76] claim that economic evaluation of telemedicine provides reliable information for decision makers before 
the implementation of the technology. However, although economic analysis takes different perspectives, [63] claim 
that cost effectiveness analysis is vital since without funding the technology will be rendered unsustainable [51]. 
 
Human factors 
 
Shortage of radiologists, increase of the aging population as well as cases of chronic diseases requiring round the 
clock checks has increased the need for the adoption of telemedicine [46][31]. In addition, the acceptance to adopt 
the new technology will greatly influence the diffusion of telemedicine [45] [70]. 
 
Technological factors 
 
According to [21], the growth of technological innovations such as high-capacity digital networks, powerful 
computer hardware and software, high-resolution digital image compression and the Internet has had a great impact 
on the process of health care delivery.  
In addition, scholars claim that healthcare technological innovations will enable healthcare to be more efficient and 
accessible to all [15] [75] [46] [40]. 
 
 
2. CONCEPT OF TECHNOLOGY INNOVATION ADOPTION 
 
Technological innovation is claimed to be the major driving force in the expedition to balance cost containment and 
quality [46]. In healthcare sector, telemedicine is considered as an innovation since it is a new technology in the 
sector. However, [68] claim that despite the potential benefits of telemedicine, its diffusion rate is very slow 
especially in developing countries. According to [13], the universal shortage of nurses and other key health 
practitioners advances the argument in favour of more technology innovation in healthcare. Nevertheless, [41] claim 
that technology adoption in healthcare is generally slow and disparate. However, the innovation adoption curve of 
telemedicine is similar to that of other health technologies and follows an S-shaped logistic growth curve [50] 
illustrated by [47] as shown in Figure 4. 
 
 
 
                                
                                     Figure 4: Technology adoption lifecycle [47] 
 
 
 
2.1 Factors influencing the technology adoption 
 
According to [47], five aspects influence the technology adoption lifecycle of any innovation. These aspects will be 
used to form the basis of the organisational aspect of the conceptual model illustrated later in Figure 8. 
 
 Relative advantage 
 
The degree to which an innovation is perceived as better than the idea it supersedes. The degree of relative 
advantage may be measured in economic terms, but social-prestige factors, convenience, and satisfaction are also 
often important components.  
 
 Compatibility  
 
The degree to which an innovation is perceived as being consistent with the existing values, past experiences, and 
needs of potential adopters. An idea 
which is not compatible with the prevalent values and 
norms of a social system will not be adopted as rapidly as an innovation that is compatible with the prevalent values 
and norms of a social system. 
 
 Complexity 
 
The degree to which an innovation is perceived as difficult to understand and use. Some innovations are readily 
understood by most members of a social system; others are more complicated and will be adopted more slowly.  
 
 Trialability  
 
The degree to which an innovation may be experimented with on a limited basis. New ideas that can be tried on the 
instalment plan will generally be adopted more quickly than innovations that are not divisible. 
 
 Observability  
 
The degree to which the results of an innovation are visible to others. The easier it is for individuals to see the results 
of an innovation, the more likely they are to adopt.   
 
Since telemedicine is an innovation like any other technological innovation [24] the above mentioned aspects have 
to be considered during the implementation of telemedicine to enhance the level of acceptance by the stakeholders 
[44][46]. However, telemedicine is an expensive project to implement [54] where a single organisation is likely to 
face challenges in funding the project. One of the major problems presented in healthcare innovations is funding the 
innovative projects such as telemedicine [32] [68] [12]. Such problems have been highly faced by the developing 
countries leading to low healthcare technological innovation adoption rate as shown in Figure 5.  
As shown in Figure 5, advanced continents such as America and Europe have a higher telemedicine growth rate in 
comparison to other continents. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
               Figure 5: Adoption of telemedicine globally [68]. 
 
 
According to [78], availability of grants funded by the federal government for telemedicine projects has greatly 
enabled the implementation of telemedicine in these continents.  However, [41] claim that telemedicine programs 
need to move from relying on grants to a profit-centered status.  
In addition, this will enable them sustain their existence by moving away from challenge related to financial 
sustainability [31]. Since development of financially sustainable telemedicine programs has been pointed out as one 
of the barriers to telemedicine adoption [1] [32] [20] claim that collaboration with other organisations is needed for 
smooth implementation of telemedicine projects.  
 
 
3. THE CONCEPT OF CO-INNOVATION 
 
Co-Innovation is an innovation that necessitates collaboration among various organisations, actors, levels or 
segments [49]. According to [16], innovation is experiencing a paradigm shift from closed innovation to open 
innovation to co-innovation. In closed innovation, organizations generate their own ideas, implement and distribute 
them to the end users. Due to the rapid changes and increase in market demand, closed innovation does not allow 
organisation expand their capabilities rapidly due to the narrow knowledge silos. As a result, open innovation 
emerged which assumes that organizations can use internal and external ideas to advance their technology [16]. 
With rapid increase in market demand, open collaboration among organisations enabled greater innovation 
capabilities. According to [48] co-innovation provide a competitive advantage by combining the best skills or core 
competencies and resources of two or more organisations, as well as customers knowledge of a product or a service 
to co-create a value proposition more compelling and relevant to the consumers’ needs and expectations. The level 
of collaboration can be between departments of an organisation or amongst various organisations either nationally or 
internationally [8] [22]. When the organisations decide to co-innovate, they enter into contracts with each other and 
agree on the distribution of costs and revenues incurred during the co-innovation process [9]. 
  
According to the Singapore government, co-innovation is about the public and private sector joining hands to create 
innovations that can help the government do its job better [53]. Execution of costly projects such as telemedicine 
may require sharing of costs and risks associated with it. Since co-innovation allows partnership where various 
actors with a shared vision collaboratively create an environment for innovation [49] [2] [8], implementing 
expensive and expansive projects can be effectively managed and risks shared across the partners. However, [42] 
claim that organisations tend to establish partnership at early phases of innovation even before the object of 
collaboration is defined. According to [52], the ability to manage such collaborations efficiently is likely to be 
complicated because there are no mutual liabilities at the early stages of the collaboration. In addition, since the 
organisations have very little knowledge of each other, time is needed to understand the corporate cultures and 
strategies of every organisation involved in the partnership [10]. 
 
Since co-innovation network consists of various parties having their own organisational policies coming together to 
solve a joint task, [22] points out five elements used to unify these parties. However, the collaborating parties must 
overcome the problems of distrust, disrespect, and outright antagonism in order to accomplish their mission [3] [7].  
 
3.1 Elements of Co-Innovation network 
 
According to [22] organisation network is the basic social form that permits inter-organizational interactions of 
exchange, converted action and joint production. Co-innovation network consist of five elements as shown in Figure 
6. 
 
 
Figure 6: Elements of Co-Innovation network 
    
 
Table 2: Elements of Co-Innovation 
 
 
 
 
 
 
 
 
 
 
 
 
 
According to [26], the stakeholders of healthcare environment create a complex innovation network so as to 
effectively respond to macro changes such as economic, technological and social changes as shown in Figure 7. 
Vision The purpose and values of the collaborating organisations 
Parties Resources of the co-innovation network i.e. the 
collaborating organisations. A fundamental element 
between the collaborating parties is trust. 
Processes Procedures needed in order to accomplish the vision of the 
collaborating organisations. They are centered on exchange 
of coordination, information and joint problem-solving 
between the organizations. 
Architecture The structural framework for collaboration. It shapes the 
structural framework for collaboration. 
Culture The norms and values for interaction among the 
organisations. 
 
 
Figure 7:  Healthcare collaboration network   [26] 
 
However, studies indicate that the complex networks complicate the decision making process since the memebers of 
a network must come to an agreement [47] [76]. 
 
4. PRELIMINARY CONCEPTUAL MODEL OF CO-INNOVATION AND TELEMEDICINE ADOPTION 
 
To undertake the research, various aspects underpinned by the literature are considered. As shown in Figure 8, five 
areas will be considered in the study. The organisations that work in partnership  
with healthcare sector such as non-profit organisations and government bodies [26] will be considered. In addition, 
patient views on healthcare innovations and factors influencing its adoption rate will also be considered. On the left 
hand side of the model are the co-innovation inputs to the healthcare provider. The main part of the model comprises 
of the healthcare provider aspects (shown on the middle block) identified from the extant literature.  
The effects of ICT on the co-innovation inputs as well as healthcare provider will also be considered. The outcomes 
of the model are yet to be defined. 
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Figure 8: PRELIMINARY CONCEPTUAL MODEL           
 
5. DISCUSSION AND CONCLUSION 
 
By developing a model that conceptualises co-innovation as a facilitator for telemedicine adoption in healthcare, this 
paper contributes to the understanding of the factors affecting organization innovation in the healthcare context. Our 
approach goes beyond the widely utilized literature on open innovation to acknowledge the costs and organization 
challenges faced by healthcare providers undertaking ICT based innovations. Hence we propose that the developed 
conceptual model offer a valuable theoretical framework for future studies on telemedicine adoption 
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